Doximity CEO awarded 2.48M stock options
Doximity, Inc. granted Chief Executive Officer Jeffrey Tangney a stock option covering 2,480,000 shares of Class A Common Stock at an exercise price of $28.02 per share, expiring July 22, 2036.
Rhea-AI Filing Summary
Doximity, Inc. granted Chief Executive Officer Jeffrey Tangney a stock option covering 2,480,000 shares of Class A Common Stock at an exercise price of $28.02 per share, expiring July 22, 2036.
The option vests in four equal annual installments beginning July 22, 2027, only if the share price equals or exceeds $28.02 for any 60 consecutive trading days between July 22, 2026 and July 22, 2030 and he remains in continuous service.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 2,480,000 shares
Grant/Award
1 txn
Insider
Tangney Jeffrey
Role
Chief Executive Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) F1 | 2,480,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 2,480,000 contracts (Direct)
Footnotes (1)
- F1. The stock option vests and becomes exercisable, if at all, in four equal annual installments beginning on July 22, 2027, if the daily closing price of the Issuer's Class A Common Stock on the New York Stock Exchange equals or exceeds $28.02 per share during any 60 consecutive trading day period from July 22, 2026 to July 22, 2030, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date. The stock option was granted on July 22, 2026.
Key Figures
Stock options granted: 2,480,000 options
Exercise price: $28.02 per share
Expiration date: July 22, 2036
+3 more
6 metrics
Stock options granted
2,480,000 options
Grant to CEO Jeffrey Tangney on July 22, 2026
Exercise price
$28.02 per share
Exercise price for the granted stock option
Expiration date
July 22, 2036
Expiration of the granted stock option
Vesting installments
4 annual installments
Option vests in four equal annual installments beginning July 22, 2027
Performance measurement window
July 22, 2026 to July 22, 2030
Period to achieve 60 consecutive trading days at or above $28.02
Price hurdle period length
60 consecutive trading days
Required period that stock must meet or exceed the $28.02 price
Key Terms
Stock Option, exercise price, vesting, continuous service relationship, +1 more
5 terms
Stock Option financial
"security_title is listed as Stock Option (Right to Buy)"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
exercise price financial
"conversion or exercise price of the option is $28.02 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"The stock option vests and becomes exercisable, if at all, in four equal annual installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
continuous service relationship financial
"subject to the Reporting Person's continuous service relationship with the Issuer"
trading day period financial
"during any 60 consecutive trading day period from July 22, 2026 to July 22, 2030"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Doximity (DOCS) report for Jeffrey Tangney?
Doximity reported that CEO Jeffrey Tangney received a stock option for 2,480,000 shares of Class A Common Stock on July 22, 2026, with an exercise price of $28.02 per share and an expiration date of July 22, 2036, subject to performance-based vesting.
What are the vesting conditions on Jeffrey Tangney’s new Doximity (DOCS) stock options?
The option vests and becomes exercisable in four equal annual installments starting July 22, 2027, only if Doximity’s Class A shares close at or above $28.02 for any 60 consecutive trading days between July 22, 2026 and July 22, 2030, with continued service.
What is the exercise price and term of the Doximity (DOCS) options granted to the CEO?
The stock option granted to CEO Jeffrey Tangney carries an exercise price of $28.02 per share and has an expiration date of July 22, 2036. This gives him a 10-year term from grant to exercise, subject to the vesting and performance conditions.
When does the performance period run for the Doximity (DOCS) CEO option grant?
The performance condition must be satisfied during the window from July 22, 2026 to July 22, 2030. During this period, Doximity’s Class A stock must close at or above $28.02 for 60 consecutive trading days for the option to begin vesting.
Is the new Doximity (DOCS) CEO option grant tied to continued employment?
Yes. Each installment of the option vests only if Tangney maintains a continuous service relationship with Doximity through the applicable vesting date, in addition to meeting the $28.02 stock price hurdle over a 60-day trading period within the specified performance window.
Was the Doximity (DOCS) CEO option grant made under a Rule 10b5-1 plan?
The filing indicates the Rule 10b5-1 checkbox was not affirmed, meaning this grant was not reported as being made under a Rule 10b5-1 trading plan. It is disclosed as a compensation-related grant/award acquisition of derivative securities.
AI-generated analysis. How Rhea-AI works. Not financial advice.
